227 related articles for article (PubMed ID: 15215126)
21. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
Yamamoto T; Litwin S; Zhou T; Zhu Y; Condreay L; Furman P; Mason WS
J Virol; 2002 Feb; 76(3):1213-23. PubMed ID: 11773397
[TBL] [Abstract][Full Text] [Related]
23. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
Siegel F; Lu M; Roggendorf M
J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
[TBL] [Abstract][Full Text] [Related]
24. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
[TBL] [Abstract][Full Text] [Related]
25. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
[TBL] [Abstract][Full Text] [Related]
26. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
Front Immunol; 2021; 12():745802. PubMed ID: 34671360
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes.
Wang Y; Jacob JR; Menne S; Bellezza CA; Tennant BC; Gerin JL; Cote PJ
J Viral Hepat; 2004 Sep; 11(5):404-17. PubMed ID: 15357645
[TBL] [Abstract][Full Text] [Related]
29. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
[TBL] [Abstract][Full Text] [Related]
30. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
31. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
[TBL] [Abstract][Full Text] [Related]
33. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.
Menne S; Tumas DB; Liu KH; Thampi L; AlDeghaither D; Baldwin BH; Bellezza CA; Cote PJ; Zheng J; Halcomb R; Fosdick A; Fletcher SP; Daffis S; Li L; Yue P; Wolfgang GH; Tennant BC
J Hepatol; 2015 Jun; 62(6):1237-45. PubMed ID: 25559326
[TBL] [Abstract][Full Text] [Related]
34. Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.
Casey J; Cote PJ; Toshkov IA; Chu CK; Gerin JL; Hornbuckle WE; Tennant BC; Korba BE
Antimicrob Agents Chemother; 2005 Oct; 49(10):4396-9. PubMed ID: 16189132
[TBL] [Abstract][Full Text] [Related]
35. A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment.
Karatayli E; Karayalçin S; Karaaslan H; Kayhan H; Türkyilmaz AR; Sahin F; Yurdaydin C; Bozdayi AM
Antivir Ther; 2007; 12(5):761-8. PubMed ID: 17713159
[TBL] [Abstract][Full Text] [Related]
36. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
[TBL] [Abstract][Full Text] [Related]
37. Clevudine for the treatment of chronic hepatitis B virus infection.
Hui CK; Lau GK
Expert Opin Investig Drugs; 2005 Oct; 14(10):1277-84. PubMed ID: 16185170
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of the type I IFN receptor in two woodchuck species and detection of its expression in liver samples from woodchucks infected with woodchuck hepatitis virus (WHV).
Fan H; Zhu Z; Wang Y; Zhang X; Lu Y; Tao Y; Fan W; Wang Z; Wang H; Roggendorf M; Lu M; Wang B; Yang D
Cytokine; 2012 Oct; 60(1):179-85. PubMed ID: 22705153
[TBL] [Abstract][Full Text] [Related]
39. Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.
Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Clark JM
Antiviral Res; 2000 Dec; 48(3):197-203. PubMed ID: 11164506
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles.
Tencza MG; Newbold JE
J Med Virol; 1997 Jan; 51(1):6-16. PubMed ID: 8986943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
